Le Lézard
Classified in: Health
Subject: SVY

United States Wound Closure Devices Market Outlook to 2024



LONDON, Oct. 6, 2017 /PRNewswire/ -- Summary
GlobalData's new report, "United States Wound Closure Devices Market Outlook to 2024", provides key market data on the United States Wound Closure Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Hemostats, Ligating Clips, Surgical Adhesion Barriers, Surgical Stapling Devices, Tissue Adhesives, Tissue Sealants and Wound Closure Strips.



Download the full report: https://www.reportbuyer.com/product/2437350



The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
- Market size and company share data for Wound Closure Devices market segments - Hemostats, Ligating Clips, Surgical Adhesion Barriers, Surgical Stapling Devices, Tissue Adhesives, Tissue Sealants and Wound Closure Strips.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
- 2017 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the United States Wound Closure Devices market.
- Key players covered include Ethicon US LLC, Medtronic plc and Baxter International Inc.

Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Download the full report: https://www.reportbuyer.com/product/2437350

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com  

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 22:52
ESSA Pharma Inc. ("ESSA" or the "Company") announces an update to its previously announced pricing press release. The Company intends to issue up to 75,000,000 units of the Company ("Units") at a price of US$0.20 per Unit (the "Offering Price") for...

at 22:50
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Endologix, Inc. .   On August 2, 2016,...

at 22:29
The food recall warning issued on December 9, 2017 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Imperial Caviar...

at 19:35
Valeant Pharmaceuticals International, Inc. ("Valeant") announced today the results to date of the pending cash tender offers (the "Tender Offers") by Valeant and Valeant Pharmaceuticals International ("VPI," and together with Valeant, the...

at 19:23
Recognizing that Centene Corporation's Washington subsidiary, Coordinated Care, has been in active discussions with the State of Washington Office of the Commissioner (OIC) for some time, today Coordinated Care finalized the terms of an agreement...

at 18:00
Aurora Cannabis Inc. ("Aurora") today announced that the Company has granted a total of 850,000 options to certain employees and directors of the Company, exercisable at $7.00 per common share. The options shall vest quarterly over a period of 36...




News published on 6 october 2017 at 09:26 and distributed by: